Skip to main content
Log in

Plasma cyclic AMP and cyclic GMP in childhood-onset psychoses

  • Published:
Journal of Autism and Developmental Disorders Aims and scope Submit manuscript

Abstract

Plasma cyclic AMP is a “second messenger” that may reflect levels of activity of important neurotransmitter receptors. Plasma cyclic AMP was measured in 18 patients with childhood autism, 7 patients with pervasive developmental disorder, and 12 age- and sex-matched healthy controls. Plasma cyclic AMP was significantly elevated by over 100% in both groups of patients with childhood-onset psychoses compared with controls. Plasma cyclic GMP, a nucleotide linked to different receptors, was not elevated, suggesting that the finding may be specific.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • American Psychiatric Association. (1980).Diagnostic and statistical manual of mental disorders (3rd ed.). Washington, D.C.

  • Belmaker, R. H., Hattab, J., Ebstein, R. P. (1978). Plasma dopamine-B hydroxylase in childhood psychoses.Journal of Autism and Childhood Schizophrenia, 8, 293–298.

    Article  PubMed  Google Scholar 

  • Belmaker, R. H., Zohar, J., & Ebstein, R. P. (1980). Cyclic nucleotides in mental disorder. In P. Hamet & H. Sands (Eds.),Advances in cyclic nucleotide research (Vol. 12, pp. 187–197). New York: Raven Press.

    Google Scholar 

  • Biederman, J., Rimon, R., Ebstein, R. P., Zohar, J., & Belmaker, R. H. (1976). Neuroleptics reduce spinal fluid cyclic AMP in schizophrenic patients.Neuropsychobiology, 2, 324–327.

    Article  PubMed  Google Scholar 

  • Broadus, A. E. (1977). Clinical cyclic nucleotide research.Advances in Cyclic Nucleotide Research, 8, 509–548.

    PubMed  Google Scholar 

  • Ebstein, R. P., Belmaker, R. H., Grunhaus, L., & Rimon, R. (1976). Lithium inhibition of adrenaline-stimulated adenylate cyclase in humans.Nature, 259, 211–213.

    Article  Google Scholar 

  • Hoshino, Y., Kumashiro, H., Yashima, Y., Kaneko, M., Numata, Y., Oshima, N., & Watanabe, A. (1980). Plasma cyclic AMP level in psychiatric diseases in childhood.Folia Psychiatrica et Neurologica Japonica, 34, 9–16.

    PubMed  Google Scholar 

  • Lykouras, E., Varsou, E., Garelis, E., Stefanis, C. N., & Malliaras, D. (1978). Plasma cyclic AMP in manic-depressive illness.Acta Psychiatrica Scandinavica, 57, 447–53.

    PubMed  Google Scholar 

  • Lykouras, E., Varsou, E., Rinieris, P., & Stefanis, C. N. (1980). Plasma cyclic AMP in schizophrenics.Progress in Neuropsychopharmacology, 4, 69–74.

    Article  Google Scholar 

  • Palmer, G. C., & Duszynski, C. R. (1975). Regional cyclic GMP content in incubated tissue of rat brain.European Journal of Pharmacology, 32, 375–379.

    Article  PubMed  Google Scholar 

  • Zohar, J., Rimon, R., Biederman, J., Ebstein, R. P., & Belmaker, R. H. (1978). Clinical correlates of CSF cyclic nucleotides in schizophrenia.American Journal of Psychiatry, 135, 253–255.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goldberg, M., Hattab, J., Meir, D. et al. Plasma cyclic AMP and cyclic GMP in childhood-onset psychoses. J Autism Dev Disord 14, 159–164 (1984). https://doi.org/10.1007/BF02409658

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02409658

Keywords

Navigation